Patents by Inventor Maria G. Pallavicini

Maria G. Pallavicini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of expressed genes using phage display
    Publication number: 20030091986
    Abstract: The n provides method of mapping polypeptide-encoding regions of genes. In particular, the invention provides methods of identifying, isolating and mapping a genomic exon sequence at the protein level using epitope phage display libraries. The invention also provides epitope- and antibody-phage display libraries and a novel phage expression vector.
    Type: Application
    Filed: November 9, 2001
    Publication date: May 15, 2003
    Applicant: REGENTS OF THE UNIVERSITY OF CALIFORNIA, Office of Technology Transfer
    Inventors: Maria G. Pallavicini, Brian P. Mullaney
  • Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity
    Patent number: 5807836
    Abstract: The present invention relates, in general, to a method of diagnosing tumorigenic mammalian cells or the propensity of a mammalian cell to become tumorigenetic. Additionally, the present invention relates to a cloned cDNA or genomic DNA for reducing the propensity of a cell to become tumorigenic or suppressing tumorigenic phenotype of a cell; a method of reducing the propensity of a cell to become tumorigenic or suppressing the tumorigenic phenotype of a cell; a method of treating a patient suffering from or predisposed to subsequent cancer development; and a method of diagnosing tumorigenic tissue of a human or tissue predisposed to become tumorigenic.
    Type: Grant
    Filed: February 23, 1995
    Date of Patent: September 15, 1998
    Assignees: The Regents of the University of California, The University of New Mexico, Tadatsugu Taniguchi
    Inventors: Tadatsugu Taniguchi, Cheryl L. Willman, Maria G. Pallavicini, Hisashi Harada, Nobuyuki Tanaka
  • Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity
    Patent number: 5652095
    Abstract: The present invention relates, in general, to a method of diagnosing tumorigenic mammalian cells or the propensity of a mammalian cell to become tumorigenetic. Additionally, the present invention relates to a cloned cDNA or genomic DNA for reducing the propensity of a cell to become tumorigenic or suppressing tumorigenic phenotype of a cell; a method of reducing the propensity of a cell to become tumorigenic or suppressing the tumorigenic phenotype of a cell; a method of treating a patient suffering from or predisposed to subsequent cancer development; and a method of diagnosing tumorigenic tissue of a human or tissue predisposed to become tumorigenic.
    Type: Grant
    Filed: September 24, 1993
    Date of Patent: July 29, 1997
    Assignees: The Regents of the University of California, The University of New Mexico, Tadatsugu Taniguchi
    Inventors: Tadatsugu Taniguchi, Cheryl L. Willman, Maria G. Pallavicini, Hisashi Harada, Nobuyuki Tanaka